General Updates

July 08, 2026 The National Stock Exchange of India Ltd BSE Limited Corporate Communications Department Corporate Services Department “Exchange Plaza”, 5th Floor, Phiroze Jeejeebhoy Towers Bandra-Kurla Complex, Bandra (East), Dalal Street, Mumbai – 400051 Mumbai – 400001 Scrip Symbol: RELIGARE Scrip Code: 532915 Subject: Disclosure of allotment of equity shares by Care Health Insurance Ltd. (CHIL) subsidiary of the company, in its rights issue in pursuance of Regulation 30 of SEBI (LODR) Regulation, 2015 Dear Sir(s), With reference to the captioned subject, we would like to inform that in response to the application of Religare Enterprises Ltd. (REL) to subscribe for equity shares of Care Health Insurance Ltd., subsidiary of the Company (CHIL) in its rights issue, made in pursuance of the approval of Board of Directors of REL at their meeting held on June 19, 2026, CHIL has made an allotment of 74,80,324 Equity shares having face value of INR 10/- (Rupees Ten) each at a premium of INR 150/- (One Hundred Fifty only) amounting to INR 1,19,68,51,840/- on June 30, 2026. Relevant details as required under Regulation 30 of the SEBI Listing Regulation read with SEBI Master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are given in Annexure-1. This is for your kind information and record. For Religare Enterprises Limited Anuj Jain Company Secretary & Compliance Officer Encl.: as above Religare Enterprises Limited CIN: L74899DL1984PLC146935 Registered Office: First Floor, Office No. 101, 2E/23, Jhandewalan Extn., New Delhi – 110055 Phone No.: +91-11- 4167 9692 Corporate Office: 1st Floor, Tower A, Club 125, Plot A-3,4, 5, Sector -125, Noida – 201301, Uttar Pradesh Phone No.: +91-120- 4384 941 www.religare.com / investorservices@religare.com Annexure-1 Details under amended Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read along with SEBI Master Circular ref. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 Sl. No Details of Events that need to be Information of such events(s) provided a. Name of the target entity, details in Care Health Insurance Limited (“CHIL”) brief such as size, turnover etc.; registered with IRDAI, being the target entity, is carrying on health Insurance Business. CHIL as is having 277 Branches and more than 13,000 professionals working for it as on March 31, 2026. CHIL has served over three million policyholders in the insurance business. b. whether the acquisition would fall Relationship:- CHIL is a material unlisted within related party transaction(s) subsidiary of Religare Enterprises Limited and whether the promoter/ (“REL”). Holding and subsidiary company are promoter group/ group companies considered related party to each other. have any interest in the entity being Accordingly, investment in the rights issue of CHIL by REL (Acquisition) can be said to be acquired? related party transaction. If yes, nature of interest and details Further, the investment in right issue of CHIL thereof and whether the same is was made at the price offered uniformly to all done at “arm length’s” the shareholders, therefore the transaction is said to be at arm’s length. Further, the promoter of REL does not have any interest in CHIL. c. Industry to which the entity being Health Insurance acquired belongs; d. Objects and effects of REL is registered with Reserve Bank of India acquisition (including but not (RBI) as Core Investment Company (CIC). As a limited to, disclosure of reasons for Core Investment Company, REL is primarily acquisition of target entity, if its engaged in the business of investment in business is outside the main line of shares/securities of and lending to, its group companies. Accordingly, REL subscribed to the business of the Company); shares of its subsidiary, CHIL, offered in rights issue. The proceeds out of right issue of CHIL shall be used to finance the expansion plans and to meet the statutory solvency requirements. e. Brief details of any governmental or Not Applicable for REL regulatory approvals required for the acquisition; f. Indicative time period for Pursuant to the letter of allotment received by completion of the acquisition; REL on July 08, 2026, acquisition is deemed to have been completed on same day. Religare Enterprises Limited CIN: L74899DL1984PLC146935 Registered Office: First Floor, Office No. 101, 2E/23, Jhandewalan Extn., New Delhi – 110055 Phone No.: +91-11- 4167 9692 Corporate Office: 1st Floor, Tower A, Club 125, Plot A-3,4, 5, Sector -125, Noida – 201301, Uttar Pradesh Phone No.: +91-120- 4384 941 www.religare.com / investorservices@religare.com g. Nature of consideration - whether Cash cash consideration or share swap and details of the same h. Cost of acquisition or the price at Acquisition of shares:- 74,80,324 equity shares which the shares are acquired; of Face Value of INR 10/- each at a Premium of INR 150/- of CHIL amounting to INR 1,19,68,51,840/- (Rupees One Hundred Nineteen Crore Sixty-Eight Lakh Fifty-One Thousand Eight Hundred Forty Only) i. Percentage of shareholding / Total Number of equity shares acquired:- control acquired and / or number 74,80,324 of shares acquired; j. brief background about the Following are the details of target entity:- entity acquired in terms of  Line of business:- Health Insurance business products/line of business acquired,  Date of incorporation:- 02.04.2007 date of incorporation, history of last  Last three years turnover (In Rs. Crores):- 3 years turnover, country in which (i) FY 2023-24:- 7,022 Crores the acquired entity has presence (ii) FY 2024-25:- 8,562 Crores and any other significant (iii) FY 2025-26:- 10,416 Crores information (in brief)  Country of operations:- India Further details about the target company can be accessed at below link:- www.careinsurance.com Religare Enterprises Limited CIN: L74899DL1984PLC146935 Registered Office: First Floor, Office No. 101, 2E/23, Jhandewalan Extn., New Delhi – 110055 Phone No.: +91-11- 4167 9692 Corporate Office: 1st Floor, Tower A, Club 125, Plot A-3,4, 5, Sector -125, Noida – 201301, Uttar Pradesh Phone No.: +91-120- 4384 941 www.religare.com / investorservices@religare.com